ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Mycoses

Mycoses

Volume 49 Issue 3, Pages 242 - 245

Published Online: 25 Apr 2006

© 2010 Blackwell Verlag GmbH



< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 63K)  | Related Articles | Citation Tracking

Letter to the editor
Successful caspofungin treatment of multidrug resistant Candida parapsilosis septicaemia in an extremely low birth weight neonate
Mehmet Yalaz 1 , Mete Akisu 1 , Suleyha Hilmioglu 2 , Sebnem Calkavur 1 , Bilin Cakmak 1 and Nilgun Kultursay 1
Departments of  1Pediatrics, and  2Microbiology and Clinical Microbiology, Ege University Medical Faculty, Ege University, Izmir, Turkey
Correspondence to Mehmet Yalaz, Departments of Pediatrics, Ege University Medical Faculty, Ege University, Izmir, Turkey.
E-mail: yalazms@superonline.com.tr and yalazms@med.ege.edu.tr
Copyright 2006 Blackwell Publishing Ltd
KEYWORDS
newborn • septicaemia • fungus • treatment • caspofungin

Summary

AbstractIntroductionCase reportDiscussionReferences

Candida septicaemia with multidrug resistance is an uncommon event in preterm neonates. We present an extremely low birth weight infant (gestational age of 27 weeks, birth weight of 980 g) who developed congenital Candida parapsilosis septicaemia. Because the fungus was resistant both to amphotericin B and fluconazole, caspofungin was chosen for therapy. The fungus was successfully eradicated without any clinical or laboratory adverse effects.


Accepted for publication 30 November 2005

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1439-0507.2006.01220.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now
E-mail alerts
Sign up for e-alerts
Sign Up Now
Wiley Medical Twitter